Publications:70
Accepting New Patients
- Mount Sinai Doctors
- Treats Adults
- Accepting New Patients
Michael Buckstein, MD, PhD
Radiation Oncology
About Me
Michael Buckstein, M.D., Ph.D. is a radiation oncologist specializing in the treatment of gastrointestinal tumors including the esophagus, stomach, pancreas, liver, gall bladder, bile ducts, rectum, and anus as well coronary brachytherapy. He uses many advanced techniques such Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), Stereotactic Body Radiation Therapy (SBRT), and brachytherapy to maximize local control and cure of the cancer while minimizing radiation side effects to healthy tissue.
Dr. Buckstein graduated from Yale University and received both a medical and doctoral degree from the University of Pennsylvania School of Medicine. His Ph.D. dissertation focused on the biochemical changes that affect the growth patterns of cells. He completed his Medical Internship at Long Island Jewish Medical Center and his Residency in Radiation Oncology at the Icahn School of Medicine at Mount Sinai where he served as Chief Resident.
Dr. Buckstein’s primary research focus is attempting to identify causes and limit treatment related toxicity from radiation therapy. In addition to large retrospective reviews identifying factors involved in disease outcomes and toxicity, he is also heavily involved in projects using genomics to identify specific individuals at risk for developing adverse side effects from treatment. He was involved in a novel study identifying genetic factors predictive for the development of erectile dysfunction following radiation for prostate cancer. His work has resulted in multiple presentations at international meetings as well publication in peer reviewed journals.
Language
English
Position
ASSOCIATE PROFESSOR | Radiation Oncology
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Research Topics
Cancer
Clinical Focus
- Anal Cancer
- Colorectal Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Liver Cancer
- Pancreatic Cancer
- Radiation Therapy
Education
PhD, University of Pennsylvania School of Medicine
MD, Perelman School Of Medicine At The University Of Pennsylvania
MD, University of Pennsylvania School of Medicine
Residency, Internal Medicine
Long Island Jewish Medical Center
Residency, Radiation Oncology
Mount Sinai Hospital
Certifications
Radiation Oncology
Awards
2013
Roentgen Resident Research Award
Radiological Society of North America
2011
Best of ASTRO Award
New York Roentgen Society
2008
John G. Clark Prize
University of Pennsylvania School of Medicine
2000
Medical Scientist Training Program Fellowship
National Institutes of Health
Research
Dr. Buckstein is the principal investigator on a study using combination trans-arterial chemo embolization (TACE) with stereotactic body radiation therapy (SBRT) as a treatment paradigm for treating large hepatocellular carcinomas. In addition, he is actively working to safely integrate SBRT into treatment paradigms for HCC.
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- Affinity Medicaid-Medicare-Essential Exchange
- Amidacare Medicaid
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - HealthPlus Medicaid
- Empire Blue Cross Blue Shield - Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Metroplus
- Multiplan PHCS
- NJ Medicaid
- NY Medicaid
- Oscar
- Oxford - Freedom and Liberty
- Partners Health Plan
- Senior Whole Health
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VNSNY Select Health Medicaid
- VillageCareMax
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Ablative Radiation for Oligoprogression: Another Promising but Unproven Role for Radiation in Hepatocellular Carcinoma. Michael Buckstein. International Journal of Radiation Oncology Biology Physics
- Evaluation of AI-based auto-contouring tools in radiotherapy: A single-institution study. Tingyu Wang, James Tam, Thomas Chum, Cyril Tai, Deborah C. Marshall, Michael Buckstein, Jerry Liu, Sheryl Green, Robert D. Stewart, Tian Liu, Ming Chao. Journal of Applied Clinical Medical Physics
- Erratum to: Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus. Yanagihara TK, Tepper JE, Moon AM, et al. Pract Radiat Oncol. 2024 Mar-Apr;14(2):134-145 (Practical Radiation Oncology (2024) 14(2) (134–145), (S187985002300276X), (10.1016/j.prro.2023.08.016)). Ted K. Yanagihara, Joel E. Tepper, Andrew M. Moon, Aisling Barry, Meritxell Molla, Jinsil Seong, Ferran Torres, Smith Apisarnthanarax, Michael Buckstein, Higinia Cardenes, Daniel T. Chang, Mary Feng, Chandan Guha, Christopher L. Hallemeier, Maria A. Hawkins, Morten Hoyer, Hiromitsu Iwata, Salma K. Jabbour, Lisa Kachnic, Jordan Kharofa, Tae Hyun Kim, Alexander Kirichenko, Eugene J. Koay, Hirokazu Makishima, Joel Mases, Jeffrey J. Meyer, Pablo Munoz-Schuffenegger, Dawn Owen, Hee Chul Park, Jordi Saez, Nina N. Sanford, Marta Scorsetti, Grace L. Smith, Jennifer Y. Wo, Sang Min Yoon, Theodore S. Lawrence, Maria Reig, Laura A. Dawson. Practical Radiation Oncology
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
4.9 out of 5
Care Provider’s Concern
5 out of 5
Likelihood to Recommend Care Provider
4.9 out of 5
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Buckstein has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.